• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合缺陷型慢病毒载体在脊髓中高效表达基因。

Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord.

机构信息

School of Biological Sciences, Royal Holloway-University of London, London, UK.

出版信息

Gene Ther. 2013 Jun;20(6):645-57. doi: 10.1038/gt.2012.78. Epub 2012 Oct 18.

DOI:10.1038/gt.2012.78
PMID:23076378
Abstract

Gene transfer to spinal cord cells may be crucial for therapy in spinal muscular atrophy, amyotrophic lateral sclerosis and spinal cord injury. Lentiviral vectors are efficient for transduction of a variety of cells, but like all integrating vectors they pose a risk of insertional mutagenesis. Integration-deficient lentiviral vectors (IDLVs) remain episomal but retain the transduction efficiency of standard integrating lentiviral vectors, particularly when the episomes are not diluted out through repeated cell division. We have now applied IDLVs for transduction of spinal cord in vitro, in explants and in vivo. Our results demonstrate similar efficiency of eGFP expression from integrating lentiviral vectors and IDLVs in most cell types analyzed, including motor neurons, interneurons, dorsal root ganglia (DRG) neurons and astroglia. IDLV-mediated expression of pro-glial-cell-derived neurotrophic factor (Gdnf) rescues motor neuron cultures from death caused by removal of exogenous trophic support. IDLVs also mediate efficient RNA interference in DRG neuron cultures. After intraparenchymal injection in the rat and mouse cervical and lumbar regions in vivo, transduction is mainly neuronal, with both motor neurons and interneurons being efficiently targeted. These results suggest that IDLVs could be efficient and safer tools for spinal cord transduction in future therapeutic strategies.

摘要

基因转移到脊髓细胞对于治疗脊髓性肌萎缩症、肌萎缩性侧索硬化症和脊髓损伤可能至关重要。慢病毒载体对于多种细胞的转导非常有效,但与所有整合载体一样,它们存在插入突变的风险。整合缺陷型慢病毒载体(IDLVs)仍然是附加体,但保留了标准整合慢病毒载体的转导效率,特别是当附加体不因通过重复细胞分裂而稀释时。我们现在已经将 IDLV 应用于体外、外植体和体内的脊髓转导。我们的结果表明,在大多数分析的细胞类型中,包括运动神经元、中间神经元、背根神经节(DRG)神经元和星形胶质细胞,整合型慢病毒载体和 IDLV 表达 eGFP 的效率相似。IDLV 介导的胶质细胞源性神经营养因子(Gdnf)表达可挽救因去除外源性营养支持而导致的运动神经元培养物死亡。IDLV 还介导 DRG 神经元培养物中的有效 RNA 干扰。在体内大鼠和小鼠颈段和腰段脑实质内注射后,转导主要是神经元性的,运动神经元和中间神经元都被有效靶向。这些结果表明,IDLV 可能是未来治疗策略中脊髓转导的有效且更安全的工具。

相似文献

1
Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord.整合缺陷型慢病毒载体在脊髓中高效表达基因。
Gene Ther. 2013 Jun;20(6):645-57. doi: 10.1038/gt.2012.78. Epub 2012 Oct 18.
2
High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors.整合缺陷型慢病毒载体经宫内途径转导脊髓运动神经元的高效性。
J Control Release. 2018 Mar 10;273:99-107. doi: 10.1016/j.jconrel.2017.12.029. Epub 2017 Dec 28.
3
Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.整合缺陷型慢病毒载体介导的人胶质细胞源性神经营养因子转基因表达对帕金森病啮齿动物模型具有神经保护作用。
Hum Gene Ther. 2014 Jul;25(7):631-41. doi: 10.1089/hum.2014.003. Epub 2014 Apr 15.
4
Intrastriatal Delivery of Integration-Deficient Lentiviral Vectors in a Rat Model of Parkinson's Disease.在帕金森病大鼠模型中向纹状体内递送整合缺陷型慢病毒载体
Methods Mol Biol. 2016;1448:175-84. doi: 10.1007/978-1-4939-3753-0_13.
5
Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.腺相关病毒和慢病毒载体介导的脑源性神经营养因子基因转移可预防急性颈脊髓损伤后红核脊髓束神经元萎缩并刺激再生相关基因表达。
Spine (Phila Pa 1976). 2007 May 15;32(11):1164-73. doi: 10.1097/BRS.0b013e318053ec35.
6
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.利用假型非整合慢病毒载体高效递送至成年和胎儿中枢神经系统。
Gene Ther. 2009 Apr;16(4):509-20. doi: 10.1038/gt.2008.186. Epub 2009 Jan 22.
7
Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.整合缺陷型慢病毒载体介导高效基因转移至人血管平滑肌细胞,同时具有最小的遗传毒性风险。
Hum Gene Ther. 2012 Dec;23(12):1247-57. doi: 10.1089/hum.2012.042. Epub 2012 Oct 26.
8
Integration-deficient lentiviral vectors: a slow coming of age.整合缺陷型慢病毒载体:姗姗来迟的成熟
Mol Ther. 2009 Aug;17(8):1316-32. doi: 10.1038/mt.2009.122. Epub 2009 Jun 2.
9
Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.基因传递至脊髓:慢病毒、腺病毒和逆转录病毒载体传递系统的比较
J Neurosci Res. 2006 Aug 15;84(3):553-67. doi: 10.1002/jnr.20968.
10
Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.在超氧化物歧化酶-1转基因小鼠中经颈脊髓递送狂犬病G蛋白假型慢病毒载体。受邀于2004年3月脊柱与周围神经疾病联合分会会议提交。
J Neurosurg Spine. 2004 Jul;1(1):128-36. doi: 10.3171/spi.2004.1.1.0128.

引用本文的文献

1
In utero therapy for spinal muscular atrophy: closer to clinical translation.脊髓性肌萎缩症的宫内治疗:更接近临床转化。
Brain. 2025 Apr 7. doi: 10.1093/brain/awaf123.
2
Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations.脊髓性肌萎缩症的基因治疗:关于优化SMN1递送以纠正所有神经和全身紊乱可能性的观点。
Neural Regen Res. 2025 Jul 1;20(7):2011-2012. doi: 10.4103/NRR.NRR-D-24-00504. Epub 2024 Jul 29.
3
Towards a Cure for Diamond-Blackfan Anemia: Views on Gene Therapy.
迈向 Diamond-Blackfan 贫血症的治愈之路:基因治疗观点。
Cells. 2024 May 27;13(11):920. doi: 10.3390/cells13110920.
4
Enhanced expression of the human Survival motor neuron 1 gene from a codon-optimised cDNA transgene in vitro and in vivo.体外和体内的优化密码子 cDNA 转基因中人类存活运动神经元 1 基因的增强表达。
Gene Ther. 2023 Dec;30(12):812-825. doi: 10.1038/s41434-023-00406-0. Epub 2023 Jun 15.
5
Integrase deficient lentiviral vector: prospects for safe clinical applications.整合酶缺陷型慢病毒载体:安全临床应用的前景。
PeerJ. 2022 Aug 12;10:e13704. doi: 10.7717/peerj.13704. eCollection 2022.
6
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through.临床应用中的非整合型慢病毒载体:概述
Biomedicines. 2022 Jan 5;10(1):107. doi: 10.3390/biomedicines10010107.
7
Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS Protein Docks.通过包含IS蛋白对接位点提高整合缺陷型慢病毒载体(IDLVs)的功能。
Pharmaceutics. 2021 Aug 6;13(8):1217. doi: 10.3390/pharmaceutics13081217.
8
The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.《旧与新:非整合慢病毒载体技术的前景》。
Viruses. 2020 Sep 29;12(10):1103. doi: 10.3390/v12101103.
9
On the development of optical peripheral nerve interfaces.论光学外周神经接口的发展
Neural Regen Res. 2019 Mar;14(3):425-436. doi: 10.4103/1673-5374.245461.
10
High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors.整合缺陷型慢病毒载体经宫内途径转导脊髓运动神经元的高效性。
J Control Release. 2018 Mar 10;273:99-107. doi: 10.1016/j.jconrel.2017.12.029. Epub 2017 Dec 28.